Inventor · disambiguated record
Christine Pasero
Also filed as: PASERO CHRISTINE
7 granted patents·4 pending applications·4 citations·filing 2008–2023
73Inventor score
Files withIMCHECK THERAPEUTICS SAS7INSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE2INST NAT SANTE RECH MED1OLIVE DANIEL1
Top patents by PatentIndex Score
11 records- 0178US11945871B2Anti-BTN3A antibodies and their use in treating cancer or infectious disordersIMCHECK THERAPEUTICS SAS·Filed 2023·Granted Apr 2, 2024·0 cites·14 claims
- 0277US8318166B2Ligands of HVEM for treating hematologic malignanciesOLIVE DANIEL·Filed 2008·Granted Nov 27, 2012·4 cites·2 claims
- 0369US11987631B2Anti-BTN3A antibodies and their use in treating cancer or infectious disordersIMCHECK THERAPEUTICS SAS·Filed 2019·Granted May 21, 2024·0 cites·14 claims
- 0468US2023272080A1Anti-btn3a antibodies and their use in treating cancer or infectious disordersIMCHECK THERAPEUTICS SAS·Filed 2022·Application pending·0 cites
- 0568US2024117041A1Antibodies having specificity for btn2 and uses thereofIMCHECK THERAPEUTICS SAS·Filed 2022·Application pending·0 cites
- 0658US12247075B2BTN3A binding proteins and uses thereofIMCHECK THERAPEUTICS SAS·Filed 2019·Granted Mar 11, 2025·0 cites·9 claims
- 0758US11572409B2Antibodies having specificity for BTN2 and uses thereofIMCHECK THERAPEUTICS SAS·Filed 2018·Granted Feb 7, 2023·0 cites·6 claims
- 0852US10005839B2Antagonist of the BTLA/HVEM interaction for use in therapyINST NAT SANTE RECH MED·Filed 2014·Granted Jun 26, 2018·0 cites·4 claims
- 0946US2016151489A1Combination of a ligand of hvem and an immunotoxin for use in therapyINSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE·Filed 2014·Application pending·0 cites
- 1044US2016122434A1Antagonist of the btla/hvem interaction for use in therapyINSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE·Filed 2014·Application pending·0 cites
- 1142US12258400B2Antibodies having specificity for BTN2 and uses thereofIMCHECK THERAPEUTICS SAS·Filed 2020·Granted Mar 25, 2025·0 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →